NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Obviously, ahead of any regulatory determination, as to the veracity of my lengthy receipted testimony, I cannot expend my carefully considered comments further.

Fortunately, the scheduled CHM meeting, created a natural pinch-point in the Process of the Regulators’ Investigations into my claims.

Which meant that now they were in receipt of detailed, pertinent patient testimony ahead of meeting, they had a statutory obligation to consider it.

Nem,

Now that your carefully considered comments have been evaluated during the CHM which was a natural pinch point, care to elaborate on these detailed, pertinent patient testimony you provided?

You basically guaranteed the CHM would review and deny the application at the March meeting, which clearly didn't happen, so what's going on with your bogus allegations?

Thanks in advance for your non-response.